Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea · Delayed Price · Currency is KRW 7,580.00
+40.00 (0.53%)
At close: May 8, 2026
Polaris AI Pharma Market Cap
Polaris AI Pharma has a market cap or net worth of 99.76 billion as of May 11, 2026. Its market cap has increased by 32.69% in one year.
Market Cap
99.76B
Enterprise Value
n/a
Revenue
63.94B
Ranking
n/a
PE Ratio
88.65
Stock Price
7,580.00
Market Cap Chart
Since May 17, 2004, Polaris AI Pharma's market cap has increased from 10.75B to 99.76B, an increase of 827.98%. That is a compound annual growth rate of 10.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 99.76B | 20.55% |
| Dec 30, 2025 | 82.76B | 16.23% |
| Dec 30, 2024 | 71.20B | -11.66% |
| Dec 28, 2023 | 80.59B | -2.68% |
| Dec 29, 2022 | 82.81B | -26.15% |
| Dec 30, 2021 | 112.13B | -24.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 130.13B |
| KOREA PHARMA | 120.85B |
| H.PIO | 114.13B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 112.61B |
| Pharos iBio | 107.32B |
| Sam-A Pharm. | 98.75B |
| Daehan Nupharm | 92.77B |
| Ahn-Gook Pharmaceutical | 90.81B |